Description: The Guideline methodology adhered to the Appraisal of Guidelines for Research and Evaluation (AGREE) II criteria. For the purpose of this guideline, pulmonary rehabilitation was defined as 'Any in-patient, out-patient, community-based or home-based rehabilitation programme of at least four weeks' duration that included exercise therapy with or without any form of education and/or psychological support delivered to patients with exercise limitation attributable to COPD'.
The working group initially developed nine key questions, which were constructed in accordance with the Population, Intervention, Control, and Outcomes (PICO) format. The questions were reviewed and agreed to by a COPD consumer group. Systematic reviews were performed for each key question and recommendations made based on the Grading of Recommendations Assessment, Development and Evaluation (GRADE) criteria.
Eight of the nine key questions relate specifically to people with COPD and one key question addresses pulmonary rehabilitation for people with bronchiectasis, interstitial lung disease, and pulmonary hypertension. The key questions focus on the effectiveness of pulmonary rehabilitation in different populations and whether effectiveness is impacted by factors such as the setting, duration of program and disease severity. Each key question is presented with a background section, summary of evidence, recommendation and justification. The guideline includes a helpful one-page summary of recommendations.
Provenance: Invited. Not peer reviewed. Description: These recommendations were published as a 24-page journal article. They used the best available evidence between 2003 and 2014, and developed a clinical practice guideline for the management of individuals at risk of or diagnosed with venous thromboembolism. The guideline development group, along with clinicians and academics who volunteered from both the Cardiovascular and Pulmonary Section and the Acute Care Section reviewed the identified literature. Evidence obtained from high-quality diagnostic studies, prognostic or prospective studies, cohort studies or randomised, controlled trials, meta-analyses or systematic reviews were considered when developing this guideline. This clinical practice guideline was evaluated using the AGREE II tool to assess the methodological quality of the guideline. This clinical practice guideline contains 14 key action statements that can be applied to adult patients (except pregnant women) across all practice settings. Each key action statement is followed by a rating of level of evidence, grade of the recommendation, and a summary of the relevant evidence. Included are strategies to implement and disseminate the guideline recommendations. 
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